Meet the First H3 Antagonist Carlat Reports

Meet the First H3 Antagonist

The Carlat Psychiatry Report, Volume 17, Number 11&12, November 2019
https://www.thecarlatreport.com/newsletter-issue/tcprv17n11-12/

From The Carlat Psychiatry Report, November 2019, Adult ADHD

Issue Links: Learning Objectives | Editorial Information

Chris Aiken, MD

Pitolisant (Wakix) is now FDA-approved for narcolepsy and is the first histamine H3 agonist released. Though used for a neurologic condition, its novel mechanism has potential psychiatric effects that are worth monitoring.

You can't view details of this content, please login or buy subscription here

Meet the First H3 Antagonist

Suggested Articles